Macular Degeneration Trial, Recruiting NCT04739319 Sponsor: Center for Eye Research Australia Condition: Macular Degeneration
Back to Macular Degeneration

Macular Degeneration Trial, Recruiting

NCT04739319
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with age-related macular degeneration (AMD), which means having at least one medium-sized deposit (called a drusen) in your eye measuring more than 63 micrometres; OR you have normal age-related eye changes with only small deposits (63 micrometres or smaller), or no eye abnormalities at all (as a comparison participant)

Who may not be able to join:

  • You have an eye condition or other health condition (apart from AMD) that could affect the ability to examine your retina (the back of your eye) or track AMD progression
  • You have a mental or physical condition that would prevent you from signing a consent form or taking part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Australian sites

Centre for Eye Research Australia, East Melbourne, Victoria
+61 3 9929 8263

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Center for Eye Research Australia
Registry
ClinicalTrials.gov
Start date
2 February 2021
Est. completion
1 November 2040

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Investigate the underlying aetiology of Age-Related Macular Degeneration; Characterise the natural history of Age-Related Macular Degeneration and factors associated with its rate of progression.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov